One code for NeoControl: 0029T

Why This Topic Matters

Coverage and coding treatment for emerging technologies can determine whether a service is billable or denied. For practices that offer incontinence-related therapies, the article helps clarify the broader payer environment and the coding references discussed in connection with this service.

Article Sections

1. Coding and coverage status for the NeoControl chair

   Introduces the service and places it in the context of Category III coding and payer coverage concerns. It also references Medicare contractor policy language related to emerging technologies.

2. How the chair is described and why reporting matters

   Summarizes the general procedure concept and notes the implications of having an established code available. It discusses the relationship between reporting, payer recognition, and reimbursement risk.

3. Medicare coverage background for biofeedback therapy

   Outlines Medicare policy background for urinary incontinence biofeedback therapy, including the setting, patient context, and general coverage framework.

4. Payer policy example and ICD-9-CM diagnosis codes

   Describes a commercial payer policy example and then lists diagnosis code references associated with urinary incontinence categories. It also includes terminology related to overflow incontinence.